OX40 ligand expressed in glioblastoma modulates adaptive immunity depending on the microenvironment: a clue for successful immunotherapy.
Shibahara I, Saito R, Zhang R, Chonan M, Shoji T, Kanamori M, Sonoda Y, Kumabe T, Kanehira M, Kikuchi T, So T, Watanabe T, Takahashi H, Iwabuchi E, Tanaka Y, Shibahara Y, Sasano H, Ishii N, Tominaga T.
Shibahara I, et al. Among authors: zhang r.
Mol Cancer. 2015 Feb 15;14:41. doi: 10.1186/s12943-015-0307-3.
Mol Cancer. 2015.
PMID: 25744203
Free PMC article.